We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.85%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$260B
AUM Growth
+$17.6B
Cap. Flow
+$9.95B
Cap. Flow %
3.83%
Top 10 Hldgs %
14.4%
Holding
8,581
New
810
Increased
3,919
Reduced
2,793
Closed
626

Sector Composition

Rank Sector Weight
1 Technology 9.74%
2 Financials 7.41%
3 Healthcare 6.49%
4 Consumer Discretionary 5.87%
5 Industrials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLZA
8201
DELISTED
Franklin FTSE South Africa
FLZA
-237
Closed -$6K
FLIY
8202
DELISTED
Franklin FTSE Italy ETF
FLIY
-459
Closed -$11K
CYTO
8203
DELISTED
Altamira Therapeutics Ltd
CYTO
-2
Closed -$6K
PRTK
8204
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-1,500
Closed -$8K
TKAT
8205
DELISTED
Takung Art Co., Ltd.
TKAT
$0 ﹤0.01%
+200
New +$147
INFI
8206
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-1,526
Closed -$3K
SURF
8207
DELISTED
Surface Oncology, Inc. Common Stock
SURF
-2,470
Closed -$12K
SAL
8208
DELISTED
Salisbury Bancorp, Inc.
SAL
-2,068
Closed -$43K
OFED
8209
DELISTED
Oconee Federal Financial Corp.
OFED
-254
Closed -$7K
NMTR
8210
DELISTED
9 Meters Biopharma
NMTR
$0 ﹤0.01%
+3
New +$90
ATTO
8211
DELISTED
Atento S.A.
ATTO
-1,056
Closed -$19K
ENTXW
8212
DELISTED
Entera Bio Ltd. Warrant
ENTXW
$0 ﹤0.01%
4,393
PSMC
8213
DELISTED
Invesco Conservative Multi-Asset Allocation ETF
PSMC
-19
Closed
PSMM
8214
DELISTED
Invesco Moderately Conservative Multi-Asset Allocation ETF
PSMM
$0 ﹤0.01%
24
-1,877
-99% -$25.3K
PSMG
8215
DELISTED
Invesco Growth Multi-Asset Allocation ETF
PSMG
$0 ﹤0.01%
1
-249
-100% -$3.55K
DCP
8216
CALL
DELISTED
DCP Midstream, LP
DCP
-512,500
Closed -$16.9M
JJU
8217
DELISTED
iPath Series B Bloomberg Aluminum Subindex Total ReturnSM ETN
JJU
-1,161
Closed -$51K
DBD
8218
CALL
DELISTED
Diebold Nixdorf Incorporated
DBD
-225,000
Closed -$2.49M
DBD
8219
PUT
DELISTED
Diebold Nixdorf Incorporated
DBD
-100
Closed -$1K
MNTV
8220
CALL
DELISTED
Momentive Global Inc. Common Stock
MNTV
-26,000
Closed -$473K
SEAC
8221
DELISTED
Seachange International Inc
SEAC
-548
Closed -$15K
ATCX
8222
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
-51
Closed -$1K
AGFS
8223
DELISTED
AgroFresh Solutions Inc
AGFS
$0 ﹤0.01%
+21
New +$55
HOLD
8224
DELISTED
AdvisorShares North Square McKee Core Reserves ETF
HOLD
-476
Closed -$47K
ALR
8225
DELISTED
AlerisLife Inc
ALR
$0 ﹤0.01%
124
-295
-70% -$1.69K

Similar funds

UBS Group's Q2 2019 Portfolio in Review

As of Q2 2019, UBS Group held 8,581 positions worth $260B, up 7.3% from $242B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group deployed $9.95B of net new capital in Q2 2019, opening 810 new positions and adding to 3,919 existing holdings. Its largest new stake was Dow Inc: 4,472,376 shares worth $221M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $377M trimmed.

  • UBS Group's largest Q2 2019 buy was Dow Inc: 4,472,376 shares worth $221M.
  • UBS Group added most to UBS Group in Q2 2019, an estimated $1.59B increase.
  • UBS Group's biggest Q2 2019 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $377M.
  • UBS Group fully exited Bemis in Q2 2019, selling an estimated $102M.
  • UBS Group's ten largest holdings make up 14% of its $260B portfolio in Q2 2019.
  • UBS Group opened 810 new positions and closed 626 in Q2 2019.
  • UBS Group's portfolio value rose 7.3% quarter-over-quarter to $260B.

Based on UBS Group's 13F filing for Q2 2019, filed 14 Aug 2019.